Negotiations between MSD and Revolution Medicines over a possible takeover – estimated to have been potentially worth up to $30 billion – have reportedly ended without agreement. That is according to ...

The next two discretionary priority vouchers to be awarded by the FDA are reported to be heading for two MSD candidates with blockbuster potential. According to Reuters, MSD – known as Merck & Co in ...

Merck & Co (MSD) is no longer in talks to acquire oncology biotech Revolution Medicines after negotiations hit a stumbling block over valuations, according to the Wall Street Journal (WSJ). Citing ...

This is read by an automated voice. Please report any issues or inconsistencies here. I genuinely love a good facial — the ritual of it, the permission to lie still for 90 minutes, the way my skin ...

Merck Sharp & Dohme (MSD) has agreed to acquire Cidara Therapeutics in a transaction valued at approximately $9.2 billion, following encouraging results from the company’s phase 2b trial of its lead ...

Tuning in Where Winds Meet is the backbone of the end-game gear grind, and the system kicks in once you start using Tier 41+ equipment. It looks simple on the surface, but there are a few rules you ...

CNBC's Robert Frank sits down for a rare and exclusive interview with bankers to America's wealthiest families, Byron Trott and Gregg Lemkau, co-CEOs of BDT & MSD Partners. Got a confidential news tip ...

It's not often you hear that driving fast can make your car perform better, but that's essentially what many car owners believed was the solution back in the day, a practice known as the Italian ...

Enlicitide significantly reduces LDL-C in patients with high cardiovascular risk MSD has announced positive results from its phase 3 CORALreef Lipids trial, showing that enlicitide decanoate, an ...

Antibody-drug conjugates (ADCs) continue to be à la mode in the oncology sector, with Merck & Co (MSD) tying up another deal to help advance its pipeline with the modality. MSD’s deal comes in the ...

RIYADH, Saudi Arabia: Lifera, a PIF Company, announces the signing of a non-binding Memorandum of Understanding (MOU) with MSD (also known as Merck & Co., Inc., Rahway, N.J., USA in the U.S. and ...

At New York’s Juilliard School of Music on Saturday, Paul Simon returned to the stage for the first time since his summer “Quiet Celebration” tour ended. While his appearance was unannounced until he ...